Melissa Fletcher (@masfletcher) header
Melissa Fletcher (@masfletcher) profile picture
Joined November 2010
Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)Photo by Melissa Fletcher (@masfletcher)
We’re saying THANK YOU to our volunteers and celebrating all that they do for Crohn’s & Colitis UK! Join us in celebrating and recognising everything they do. Find out more here: crohnsandcolitis.org.uk/news… #VolunteersWeek
6
19
1,190
Today is World IBD Day. Sending love to everyone affected by Crohn’s Disease, Ulcerative Colitis or any other form of IBD. #WorldIBDDay #Crohns #Colitis #IBD #CourageLooksLikeThis
4
91
9
291
16,744
Melissa Fletcher retweeted
World IBD Day: a call to arms I’m asking our global IBD community—patients, clinicians, researchers, industry, tech and policy-makers—to rally around three clear goals. 1️⃣ Implement what already works — everywhere We have the tools; we’re just not using them universally. • Faster diagnosis → fewer complications • Early, optimal therapy → healed mucosa, fewer flares • Tight monitoring & rapid action Equity of care: tackle cost, access, education If we did only this, outcomes worldwide would leap forward. 2️⃣ Do all of it better To refine every step we need modern science, tech and coordination. • Liberate knowledge—open data, clear summaries • Smarter trials—minimal placebo, no duplication, global reach • Big-data + AI guidance in real time • Shared funding & infrastructure across academia, industry and patients The payoff: targeted therapies, smart combinations, minimal side-effects and friction-free monitoring within a decade. 3️⃣ Prediction, prevention & cure Predict course after diagnosis—who flares, which drug, when? Predict IBD before it starts—especially in the general population and across Asia & Africa, the next epicentres. Prevention in the general population: better food systems, curb antibiotic overuse Prevention in the high-risk: short-term interception with existing drugs Cure—the summit, built on prediction and prevention. The call • Deliver what already works—everywhere. • Make every step better—through joined-up research, funding and tech. • Drive prediction → prevention → cure. Some we can execute today; some we’re building; some will mature with time—but together it’s a message of hope. Patients: may you get the care you need. Healthcare teams: thank you for delivering care and pushing the field forward. Industry, big tech, society: we need your smarts and investment. World IBD Day is our moment. Let’s get to work. — Charlie from Atomic IBD
10
30
4
104
8,656
💜 Happy World IBD day 💜 #IBDAwareness #2025 @CrohnsColitisUK @IBDUKTEAM
The journey with IBD is life long & isnt always plain sailing.🏥 I'm a proud patient member of @IBDUKTEAM. I'm a advocate for service improvements & patient proactivity IBD maybe invisible but we the patients are NOT💜 #FaceTheFacts #CrohnsandColitisAwarenessWeek
1
21
Melissa Fletcher retweeted
2
4
187
World IBD Day is one week away! 💜🌍 On 19th May, we stand together for the 500,000 people in the UK living with Crohn’s or Colitis. This year, we’re talking about courage. Share what courage means to you! For resources and ideas visit: crohnsandcolitis.org.uk/get-… #WorldIBDDay
28
4
67
4,186
For anyone who is interested. I'll be there along with my other lovely IBD friends. I may also be providing a small update on how to use my medical records from a patient perspective... #patientvoice #IBDAwareness #StrongerTogether #Southampton 💜
26
Join our Young Adults Advisory Panel! Join us, and help make meaningful change for people your age living with Crohn’s or Colitis 💜 Find out more: youarevalued.co.uk/jobs-boar… #YAAP #Crohns #Colitis
4
9
1,373
Invisible illness doesn’t mean non-existent illness.. #Crohns #Colitis #InflammatoryBowelDisease #IBD #HiddenIllness #hiddendisability
34
83
4,119
Without diagnosis, without the right treatment Crohn’s and Colitis can be life threatening. People who experience delays to diagnosis are twice as likely to need surgery. #CutTheCrap Don’t ignore your symptoms, use our symptom checker today: ow.ly/NBHv50QxbZA
13
31
8
60
21,509
The journey with IBD is life long & isnt always plain sailing.🏥 I'm a proud patient member of @IBDUKTEAM. I'm a advocate for service improvements & patient proactivity IBD maybe invisible but we the patients are NOT💜 #FaceTheFacts #CrohnsandColitisAwarenessWeek
1
2
4
411
Become part of our movement to make change happen by getting the IBD UK report recommendations adopted by hospitals UK-wide. Post a selfie, tag us and use the hashtag #FaceTheFacts. #crohnsandcolitisawarenessweek
18
1
34
2,397
We are delighted to announce the launch of Crohn’s & Colitis UK – The Healthcare Professional Podcast. A new way to deliver updates and education to you, our healthcare professional community. Listen here: podcasts.apple.com/us/podcas…
1
7
36
1,656
It's #CrohnsandColitisAwarenessWeek it’s time to #FaceTheFacts We hear too many stories of late intervention, delayed diagnosis & emergency A&E visits. Help us drive change to ensure better quality of care and life for people with IBD. Visit: ow.ly/2c5a50Ui59N
62
2
78
8,368
Join us on **3rd and 7th December** for our virtual social event! Giving you the chance to chat, share experiences and potentially learn from others affected by Crohn’s or Colitis. Register here: ow.ly/2Lkr50UhLEs #Crohns #Colitis #InflammatoryBowelDisease #IBD
11
16
1,430
Invisible illness doesn’t mean non-existent illness.. #Crohns #Colitis #InflammatoryBowelDisease #IBD #IBDMythBusting #HiddenIllness #hiddendisability
45
87
4,581
Melissa Fletcher retweeted
Do you live with inflammatory bowel disease? Watch this 👉 • Why you should get your calprotectin checked • and what you should do with the result
9
25
3
157
16,644
Calling all healthcare professionals📢 Join @IBDUKTeam and @CrohnsColitisUK for the virtual launch of our new report: The State of IBD Care in the UK, Thurs 12 December, 6pm. Register here: r1.dotdigital-pages.com/p/4X… #IBD #InflammatoryBowelDisease #IBDReport
1
10
1
18
2,900
Melissa Fletcher retweeted
There is a high variation in standards of IBD care We see this across Scotland, rest of UK and globally The best way to improve outcomes for IBD patients is to implement what we know works to all This involves much greater consistency of care delivery Plenty of work still to do here
6
12
2
56
5,602
Thank you @charlie_lees 🙏 very interesting. "Patients front and centre"...optimisation of therapies...powerful messaging #patientvoice @IBDUKTEAM #IBD
Positioning of drugs in Crohn's disease ___ 1. Start effective therapy early This means at diagnosis in the vast majority of patients. Don’t make patients earn their way onto an effective drug. And use your best drug first. Please do not “save it in case you need it later”. ___ 2. Which of our effective therapies should you start? This matters less that just starting. Think holistically with a patient-centered approach. Age, co-morbidities, extra-intestinal manifestations, pregnancy, etc all important. Consider efficacy - speed of onset, mucosal healing, durability of remission - and safety. Mode of delivery - intravenous, subcutaneous, oral - is important. But comes after patient factors, efficacy and safety. Access issues will predominate for many. Use what you have. Use what you know. Just use an effective drug. ___ 3. Use a treat-to-target approach Without labouring the points around STRIDE-2, I’ll put it very simply: - monitor, monitor, monitor act on the results of the monitoring. Don’t keep going with a therapy that isn’t working. ___ 4. Know when to dose optimise versus switch Optimising anti-TNF is often a good ploy. But do it properly and don’t wait too long. Double the dose, shorten the frequency and wait 2-3 cycles. If it isn’t working then (objectively), switch out of class. With ustekinumab, I would no longer dose optimise, but rather switch a partial responder to risankizumab. ___ 5. Active disease is more dangerous than any drugs Two bits of data this year show this: i) In Profile, patients in the step-up group had twice as many adverse events as those in the top-down group. Most of this was because of flaring Crohn’s disease - including hospitalisations for severe disease - but there were also fewer serious infections in the top down group. And that was with combination infliximab and azathioprine. ii) Two meta-analyses of the harms from placebo in RCT’s show a very clear signal. Active Crohn’s disease and UC, when left untreated for even a number of week, is associated with increased toxicity. More on this later. ___ 6. Avoid steroids The majority of patients with Crohn’s disease can be managed effectively now without steroids. They will still have a role in sick patients, to bridge to some therapies, and a course of budesonide in mild to moderate ileal Crohn’s disease is often useful. However we have better strategies now, including using JAK inhibitors in place of steroids. We are increasingly using a short course to (re)capture response to a biologic or keeping the JAKi going in combination at a low dose. ___ 7. Other treatment modalities Surgery and nutritional therapy are particularly important. ___ 8. Changing the natural history of Crohn’s disease Disease modification is the end result when following these principles. We see it in the Edinburgh IBD clinic. A decade since we switched to a top-down strategy for Crohn’s disease and our patients have better disease control, less surgery and fewer hospitalisations. Clearly we still have work to do, but this is major progress.
42